Pharmacotherapy for hospital-acquired pneumonia

Author： Liapikou Adamantia Rosales-Mayor Edmundo Torres Antonio

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.6, 2014-04, pp. : 775-786

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Telavancin ATTAINs benefit in hospital-acquired pneumonia

Inpharma, Vol. 1, Iss. 1664, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Aerosolised Antibacterials for the Prevention and Treatment of Hospital-Acquired Pneumonia

By Wood G. Christopher Swanson Joseph M.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 903-914

Adis International

Access to resources Recommend Favorite

Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia

By Lagacé-Wiens Philippe RS

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 6, 2013-06 ,pp. : 789-799

Informa Healthcare

Access to resources Recommend Favorite

Hospital acquired pneumonia

By Lim Wei Shen Macfarlane John T

Clinical Medicine, Vol. 1, Iss. 3, 2001-05 ,pp. : 180-184

Royal College Of Physicians

Access to resources Recommend Favorite

Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care

By Koulenti Despoina Rello Jordi

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1555-1569

Informa Healthcare

Access to resources Recommend Favorite